BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//BioCatalystFeed//bcf//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:BioCatalystFeed OCUL catalysts
X-WR-CALDESC:Scheduling/reference data from public records\; dates can move
 . Not investment\, legal or medical advice.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:af1468c7faa540f78bcb@biocat.ai
DTSTAMP:20261118T181353Z
DTSTART;VALUE=DATE:20270108
DTEND;VALUE=DATE:20270109
SUMMARY:OCUL P3 readout (est.): Study to Evaluate the Efficacy and Safety o
 f Intravitreal OTX-TKI (Axitinib Implant) in Subjects With Neovascular Age
 - Related Macular Degeneration
DESCRIPTION:Study to Evaluate the Efficacy and Safety of Intravitreal OTX-T
 KI (Axitinib Implant) in Subjects With Neovascular Age- Related Macular De
 generation\nNCT06495918 | PHASE3 | ACTIVE_NOT_RECRUITING | sponsor: Ocular
  Therapeutix\, Inc.\nPrimary completion date (ESTIMATED)\; top-line result
 s usually follow later.\nTicker OCUL (confidence 0.9)\nSource: https://cli
 nicaltrials.gov/study/NCT06495918\nScheduling/reference data from public r
 ecords\; dates can move. Not investment\, legal or medical advice.
TRANSP:TRANSPARENT
URL:https://clinicaltrials.gov/study/NCT06495918
CATEGORIES:readout,ESTIMATED
END:VEVENT
END:VCALENDAR
